265 related articles for article (PubMed ID: 15617018)
1. Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit.
Clark RL; White TE; A Clode S; Gaunt I; Winstanley P; Ward SA
Birth Defects Res B Dev Reprod Toxicol; 2004 Dec; 71(6):380-94. PubMed ID: 15617018
[TBL] [Abstract][Full Text] [Related]
2. Study on the developmental toxicity of combined artesunate and mefloquine antimalarial drugs on rats.
Boareto AC; Müller JC; de Araujo SL; Lourenço AC; Lourenço EL; Gomes C; Minatovicz B; Lombardi N; Paumgartten FR; Dalsenter PR
Reprod Toxicol; 2012 Dec; 34(4):658-64. PubMed ID: 23069110
[TBL] [Abstract][Full Text] [Related]
3. Developmental and reproductive toxicity studies on artemisone.
Schmuck G; Klaus AM; Krötlinger F; Langewische FW
Birth Defects Res B Dev Reprod Toxicol; 2009 Apr; 86(2):131-43. PubMed ID: 19306395
[TBL] [Abstract][Full Text] [Related]
4. Embryotoxicity of the artemisinin antimalarials and potential consequences for use in women in the first trimester.
Clark RL
Reprod Toxicol; 2009 Nov; 28(3):285-96. PubMed ID: 19447170
[TBL] [Abstract][Full Text] [Related]
5. Sensitive periods for developmental toxicity of orally administered artesunate in the rat.
White TE; Clark RL
Birth Defects Res B Dev Reprod Toxicol; 2008 Aug; 83(4):407-17. PubMed ID: 18615704
[TBL] [Abstract][Full Text] [Related]
6. Different embryo-fetal toxicity effects for three VLA-4 antagonists.
Crofts F; Pino M; DeLise B; Guittin P; Barbellion S; Brunel P; Potdevin S; Bergmann B; Hofmann T; Lerman S; Clark RL
Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):55-68. PubMed ID: 15098199
[TBL] [Abstract][Full Text] [Related]
7. Developmental toxicity studies of lumefantrine and artemether in rats and rabbits.
Clark RL; Youreneff M; DeLise AM
Birth Defects Res B Dev Reprod Toxicol; 2016 Dec; 107(6):243-257. PubMed ID: 28032463
[TBL] [Abstract][Full Text] [Related]
8. Prenatal developmental toxicity of decabromodiphenyl ethane in the rat and rabbit.
Hardy ML; Mercieca MD; Rodwell DE; Stedeford T
Birth Defects Res B Dev Reprod Toxicol; 2010 Apr; 89(2):139-46. PubMed ID: 20437473
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits.
Cook JC; Jacobson CF; Gao F; Tassinari MS; Hurtt ME; DeSesso JM
Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):5-26. PubMed ID: 12852480
[TBL] [Abstract][Full Text] [Related]
10. Profiling the activity of environmental chemicals in prenatal developmental toxicity studies using the U.S. EPA's ToxRefDB.
Knudsen TB; Martin MT; Kavlock RJ; Judson RS; Dix DJ; Singh AV
Reprod Toxicol; 2009 Sep; 28(2):209-19. PubMed ID: 19446433
[TBL] [Abstract][Full Text] [Related]
11. Reproductive safety studies with genistein in rats.
McClain RM; Wolz E; Davidovich A; Edwards J; Bausch J
Food Chem Toxicol; 2007 Aug; 45(8):1319-32. PubMed ID: 17433519
[TBL] [Abstract][Full Text] [Related]
12. Artesunate-induced depletion of embryonic erythroblasts precedes embryolethality and teratogenicity in vivo.
White TE; Bushdid PB; Ritter S; Laffan SB; Clark RL
Birth Defects Res B Dev Reprod Toxicol; 2006 Oct; 77(5):413-29. PubMed ID: 17066416
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the developmental toxicity of artemether during different phases of rat pregnancy.
El-Dakdoky MH
Food Chem Toxicol; 2009 Jul; 47(7):1437-41. PubMed ID: 19332101
[TBL] [Abstract][Full Text] [Related]
14. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R
Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
[TBL] [Abstract][Full Text] [Related]
15. Effects of artemisinins on reticulocyte count and relationship to possible embryotoxicity in confirmed and unconfirmed malarial patients.
Clark RL
Birth Defects Res A Clin Mol Teratol; 2012 Feb; 94(2):61-75. PubMed ID: 22125126
[TBL] [Abstract][Full Text] [Related]
16. Maternal toxicity of nonsteroidal anti-inflammatory drugs as an important factor affecting prenatal development.
Burdan F; Szumilo J; Klepacz R
Reprod Toxicol; 2009 Sep; 28(2):239-44. PubMed ID: 19379806
[TBL] [Abstract][Full Text] [Related]
17. Effects of the combined artesunate and mefloquine antimalarial drugs on rat embryos.
Boareto AC; Müller JC; Lourenço EL; Lombardi N; Lourenço AC; Rabitto I; de Morais RN; Rios FS; Dalsenter PR
Hum Exp Toxicol; 2013 Sep; 32(9):930-41. PubMed ID: 23424214
[TBL] [Abstract][Full Text] [Related]
18. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
[TBL] [Abstract][Full Text] [Related]
19. Developmental toxicity of thiodiglycol in Sprague-Dawley rats.
Houpt JT; Crouse LC; Angerhofer RA; Leach GJ; Reddy G
Int J Toxicol; 2007; 26(4):365-71. PubMed ID: 17661228
[TBL] [Abstract][Full Text] [Related]
20. Effects of low-level arsenic exposure on the developmental toxicity of anilofos in rats.
Aggarwal M; Wangikar PB; Sarkar SN; Rao GS; Kumar D; Dwivedi P; Malik JK
J Appl Toxicol; 2007; 27(3):255-61. PubMed ID: 17304642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
